HCA Healthcare
S&P 500
$426.94
+1.36%
Delayed · cached 15 min
Fair value analysis
HCA
HCA Healthcare
$426.94
Close used for this calculation
$629.99Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
53/100
Quality radar
Consensus fair value
$629.99
Below FV▲ +47.6% against the close used
Model range $451.57 – $814.06
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear$451.57Fair value$629.99Bull$814.06
FairClose
52-week traded range
52W low $361.3252W high $545.13
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
HCA Healthcare closed at $426.94, 32.2% below the consensus fair value of $629.99 drawn from 6 valuation models.
Financial DNA score 53/100 — Good. P/E of 15.1x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
$637.59
+49.3%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
P/E Fair Value
$566.60
+32.7%
EPS × 20x (sector P/E)
EPS=28.33, Sector P/E=20x
Peter Lynch (PEG)
$539.69
+26.4%
EPS × Growth% (PEG = 1 is fair)
EPS=28.33, g=19.1%
EV/EBITDA
$814.06
+90.7%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=13.36B
Reverse DCF
$426.94
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 3.3% | Historical: 19.1%
Margin of Safety
$451.57
+5.8%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=602.1, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.